explore -WSS

explore

author：explore 2025-09-27 19:28:06 - browse：11459

Colorful illustration of scientists using computers and Artificial Intelligence technology to visualize proteins for drug development – biotech coverage from STAT — Mike Reddy for STAT

David Reese calls it a “hinge moment” — the turning point when biotech and big tech merge to attack human disease with artificial intelligence.

At Amgen, where he’s led drug research and development since 2018, Reese said this moment has finally arrived. The proof lies not only in organizational changes, such as his recent appointment as the company’s first chief technology officer, but also in Amgen’s broader push to embed AI into every aspect of the drug discovery process.

“We’re now seeing 10-fold improvements in these (AI) models every six months,” said Reese, a medical oncologist by training. He added that the quickening pace of advancement means investing in the technology is no longer optional: “It’s something we must do to have a practical, pragmatic impact on drug discovery.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： Is it ever OK for doctors to lie to their patients?

focus

WSS

Chemotherapy before breast cancer surgery might fuel metastasis

Sepsis can kill a child within hours. Here's how hospitals are fighting back

European officials brace for rough respiratory virus season

Novel spinal cord stimulator treats paralysis without surgery

As health system earnings go up, health insurance stocks go down

Study points to new risk in gene therapy death of Terry Horgan

entertainment

explore

explore

The high cost of giving birth even with insurance

How a small hospital in rural Puerto Rico survived Hurricane Maria

In age of alternative facts, a scholarly course on calling out crap

RSV injection headlines need to be accurate for good uptake

The cancer drug shortage isn’t new — and neither are the solutions

Setback for rare diseases as Taysha Gene Therapies pulls back

Alkermes shareholders re

Lawmakers grill UnitedHealth CEO on Change cyberattack

DIEP, the 'gold standard' of breast reconstruction, is under threat

What will Novo Nordisk's VC do with its influx of cash?

Wikipedia

2023 Nobel Prize in Medicine goes to Karikó and Weissman

RSV injection headlines need to be accurate for good uptake

Is it ever OK for doctors to lie to their patients?

RSV injection headlines need to be accurate for good uptake

WHO recommends second malaria vaccine

Experts study whether long Covid risk adds up with each reinfection

focus

hotspot

leisure time

focus